PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2014 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Pacific Biosciences Of California, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2014 to Q2 2024.
  • Pacific Biosciences Of California, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 272M shares, a 8.92% increase year-over-year.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 254M shares, a 13% increase from 2022.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 225M shares, a 10% increase from 2021.
  • Pacific Biosciences Of California, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 204M shares, a 23.6% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 272M +22.3M +8.92% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 270M +27.5M +11.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 254M +29.1M +13% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 255M +29.9M +13.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 250M +25.6M +11.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 242M +19.7M +8.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 225M +20.4M +10% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 225M +22.9M +11.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 224M +25.9M +13.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 222M +27.5M +14.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 204M +38.9M +23.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 202M +35.3M +21.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 199M +44.4M +28.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 195M +41.3M +26.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 165M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 167M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 154M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 153M +2.18M +1.44% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 151M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2016 92.1M +16.9M +22.5% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-04
Q4 2015 78.3M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 75.2M +4.47M +6.31% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 74.7M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 74.1M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q3 2014 70.7M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.